Article
Targeting the hedgehog pathway to treat basal cell carcinoma.
Journal of drugs in dermatology : JDD - 1 May 2013
Geeraert Pieter, Williams Jonathan S, Brownell Isaac
Abstract excerpt
The discovery of mutations that activate hedgehog (Hh) signaling in basal cell carcinoma (BCC) and other cancers has spurred the development of small molecule inhibitors that target the Hh pathway. High-throughput screens have identified a number of drug candidates that antagonize smoothened (SMO...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
